Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Sony Buys Stake In Bandai Namco

Deadline on MSN · 2d
Sony Pays $464M For Stake In ‘Pac-Man' Owner Bandai Namco
Sony Corp. has taken a small stake in Tekken and Pac-Man games giant Bandai Namco, as part of a strategic business alliance. Japan-based Sony paid 68 billion yen ($464M) for a 2.5% stake in its compatriot company,
Variety on MSN · 2d
Sony Takes Strategic Stake in Bandai Namco With $464 Million Deal
Sony acquires 2.5% stake in Bandai Namco for $464 million as entertainment giants partner to expand anime and manga IP globally in booming market.
CGMagazine on MSN · 2d
Sony Acquires 2.5% of Bandai Namco in a Lucrative Strategic Partnership
Sony and Bandai Namco announced a strategic partnership that makes the console maker a 2.5% shareholder in FromSoftware's publisher.
1d

Sony and Bandai Namco Form 68 Billion Yen Strategic Alliance to “Unlock Potential of Compelling IP”

Sony and Bandai Namco have formed a strategic partnership to collaborate on new IP releases for games, music, and Anime.
Screen Rant on MSN2d

Sony Announces a Major Anime Partnership With $500 Million Acquisition

Sony has announced a multimillion-dollar deal that assures anime fans that there is more in store for them long-term ...
Gamepressure
1d

Sony is closing in on Elden Ring's devs. Nightreign and Shadow of the Erdtree DLC are big wins for FromSoftware

Shadow of the Erdtree and Elden Ring: Nightreign. Sony, meanwhile, announced a major investment in its partnership with ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy